4.8 Review

Genetics of Human Cardiovascular Disease

期刊

CELL
卷 148, 期 6, 页码 1242-1257

出版社

CELL PRESS
DOI: 10.1016/j.cell.2012.03.001

关键词

-

资金

  1. NHLBI/NIH
  2. Foundation Leducq
  3. Massachusetts General Hospital
  4. Pfizer
  5. Merck
  6. Alnylam
  7. Shire Therapeutics
  8. California Institute for Regenerative Medicine
  9. Younger Family Foundation
  10. Roddenberry Foundation
  11. Whittier Foundation

向作者/读者索取更多资源

Cardiovascular disease encompasses a range of conditions extending from myocardial infarction to congenital heart disease, most of which are heritable. Enormous effort has been invested in understanding the genes and specific DNA sequence variants that are responsible for this heritability. Here, we review the lessons learned for monogenic and common, complex forms of cardiovascular disease. We also discuss key challenges that remain for gene discovery and for moving from genomic localization to mechanistic insights, with an emphasis on the impact of next-generation sequencing and the use of pluripotent human cells to understand the mechanism by which genetic variation contributes to disease.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据